WallStreetZenWallStreetZen

NASDAQ: LPTX
Leap Therapeutics Inc Stock Ownership - Who owns Leap Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Leap Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jason BaumChief Scientific Officer2025-03-286,604$0.32
$2.09kSell
Christine GranfieldVP Head of Reg AffairsQual2025-03-286,604$0.32
$2.09kSell
Augustine LawlorChief Operating Officer2025-03-287,797$0.32
$2.47kSell
Christopher MirabelliChairman of the Board2025-03-286,672$0.32
$2.12kSell

1 of 1

LPTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LPTX insiders and whales buy or sell their stock.

LPTX Shareholders

What type of owners hold Leap Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC14.96%8,476,496$17.38MInsider
Beigene Ltd12.97%7,348,437$15.06MInsider
Gilead Sciences Inc9.39%5,319,148$10.90MInsider
Gilead Sciences Inc9.39%5,319,148$10.90MInstitution
Healthcare Ventures IX LP7.32%4,144,804$8.50MInsider
John W. Littlechild4.62%2,618,406$5.37MInsider
Augustine Lawlor3.03%1,718,454$3.52MInsider
Douglas E. Onsi2.72%1,542,971$3.16MInsider
Lilly Co Eli2.61%1,479,307$3.03MInsider
Christopher Mirabelli2.57%1,457,739$2.99MInsider

1 of 3

LPTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LPTX24.29%60.82%Net Selling
STTK45.33%23.51%Net BuyingNet Buying
UNCY23.94%21.29%
FATE53.87%46.13%Net Buying
SEER47.01%52.99%Net SellingNet Selling
View Top Biotech Stocks

Leap Therapeutics Stock Ownership FAQ

Who owns Leap Therapeutics?

Leap Therapeutics (NASDAQ: LPTX) is owned by 24.29% institutional shareholders, 60.82% Leap Therapeutics insiders, and 14.89% retail investors. Perceptive Advisors LLC is the largest individual Leap Therapeutics shareholder, owning 8.48M shares representing 14.96% of the company. Perceptive Advisors LLC's Leap Therapeutics shares are currently valued at $17.38M.

If you're new to stock investing, here's how to buy Leap Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.